These drugs include semaglutide (Ozempic for diabetes, Wegovy for weight management), liraglutide (Victoza for diabetes, Saxenda for weight management), dulaglutide (Trulicity for diabetes only), and tirzepatide (Mounjaro for diabetes, Zepbound for weight management)with tirzepatide being a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not solely a GLP-1 agonist
Han YH, Kim SH, Kim SZ, Park WH
A small, travel-sized sharps container (or a sturdy plastic bottle as a temporary alternative)
BPC-157 has been shown to counteract NSAID-induced gastrointestinal damage in animal models (Sikiric et al., 2016)
Collectively, these findings establish PKM2 as a pivotal metabolic checkpoint, whose allosteric regulation offers a compelling strategy for immunomodulation by skewing the balance away from pro-inflammatory Th17 responses and toward Treg cell functions
A 2024 review in the Journal of Clinical Investigation found no increased risk of pancreatitis or pancreatic cancer with long-term GLP-1 use